These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10029309)

  • 1. Purification, characterization, and drug susceptibility of tubulin from Leishmania.
    Werbovetz KA; Brendle JJ; Sackett DL
    Mol Biochem Parasitol; 1999 Jan; 98(1):53-65. PubMed ID: 10029309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular effects of leishmanial tubulin inhibitors on L. donovani.
    Havens CG; Bryant N; Asher L; Lamoreaux L; Perfetto S; Brendle JJ; Werbovetz KA
    Mol Biochem Parasitol; 2000 Oct; 110(2):223-36. PubMed ID: 11071278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered tubulin dynamics, localization and post-translational modifications in sodium arsenite resistant Leishmania donovani in response to paclitaxel, trifluralin and a combination of both and induction of apoptosis-like cell death.
    Jayanarayan KG; Dey CS
    Parasitology; 2005 Aug; 131(Pt 2):215-30. PubMed ID: 16145938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the microtubule stabilising agent taxol on leishmanial protozoan parasites in vitro.
    Kapoor P; Sachdeva M; Madhubala R
    FEMS Microbiol Lett; 1999 Jul; 176(2):429-35. PubMed ID: 10427726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of leishmanias but not host macrophages by the antitubulin herbicide trifluralin.
    Chan MM; Fong D
    Science; 1990 Aug; 249(4971):924-6. PubMed ID: 2392684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania tarentolae: purification and characterization of tubulin and its suitability for antileishmanial drug screening.
    Yakovich AJ; Ragone FL; Alfonzo JD; Sackett DL; Werbovetz KA
    Exp Parasitol; 2006 Dec; 114(4):289-96. PubMed ID: 16753146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin.
    Bhattacharya G; Salem MM; Werbovetz KA
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2395-8. PubMed ID: 12161141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of a taxol-resistant Leishmania donovani promastigote mutant that exhibits a multidrug-resistant phenotype.
    Kapoor P; Ghosh A; Madhubala R
    FEMS Microbiol Lett; 1999 Jul; 176(2):437-41. PubMed ID: 10427727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective antimicrotubule activity of N1-phenyl-3,5-dinitro-N4,N4-di-n-propylsulfanilamide (GB-II-5) against kinetoplastid parasites.
    Werbovetz KA; Sackett DL; Delfín D; Bhattacharya G; Salem M; Obrzut T; Rattendi D; Bacchi C
    Mol Pharmacol; 2003 Dec; 64(6):1325-33. PubMed ID: 14645662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel alkyl phosphocholine-dinitroaniline hybrid molecule exhibits biological activity in vitro against Leishmania amazonensis.
    Godinho JL; Georgikopoulou K; Calogeropoulou T; de Souza W; Rodrigues JC
    Exp Parasitol; 2013 Sep; 135(1):153-65. PubMed ID: 23845259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle.
    Jordan A; Hadfield JA; Lawrence NJ; McGown AT
    Med Res Rev; 1998 Jul; 18(4):259-96. PubMed ID: 9664292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered transport properties of pentamidine-resistant Leishmania donovani and L. amazonensis promastigotes.
    Basselin M; Lawrence F; Robert-Gero M
    Parasitol Res; 1997; 83(5):413-8. PubMed ID: 9197387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vinca site agents induce structural changes in tubulin different from and antagonistic to changes induced by colchicine site agents.
    Sackett DL
    Biochemistry; 1995 May; 34(21):7010-9. PubMed ID: 7766610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Cytochrome bc1 Complex of Leishmania Parasites for Discovery of Novel Drugs.
    Ortiz D; Forquer I; Boitz J; Soysa R; Elya C; Fulwiler A; Nilsen A; Polley T; Riscoe MK; Ullman B; Landfear SM
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4972-82. PubMed ID: 27297476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents.
    Esteves MA; Fragiadaki I; Lopes R; Scoulica E; Cruz ME
    Bioorg Med Chem; 2010 Jan; 18(1):274-81. PubMed ID: 19926293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhizoxin binding to tubulin at the maytansine-binding site.
    Takahashi M; Iwasaki S; Kobayashi H; Okuda S; Murai T; Sato Y
    Biochim Biophys Acta; 1987 Dec; 926(3):215-23. PubMed ID: 3120782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the anti-microtubule compound tubulozole on Leishmania protozoan parasites in vitro.
    Fong D
    FEMS Microbiol Lett; 1993 Feb; 107(1):95-9. PubMed ID: 8468004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perifosine Mechanisms of Action in Leishmania Species.
    López-Arencibia A; Martín-Navarro C; Sifaoui I; Reyes-Batlle M; Wagner C; Lorenzo-Morales J; Maciver SK; Piñero JE
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function analysis of antimicrotubule dinitroanilines against promastigotes of the parasitic protozoan Leishmania mexicana.
    Chan MM; Tzeng J; Emge TJ; Ho CT; Fong D
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1909-13. PubMed ID: 7818612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of itraconazole and terbinafine on Leishmania promastigotes.
    Zakai HA; Zimmo SKh; Fouad MA
    J Egypt Soc Parasitol; 2003 Apr; 33(1):97-107. PubMed ID: 12739804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.